• Je něco špatně v tomto záznamu ?

Telemedicine maintains good glucose control in children with type 1 diabetes but is not time saving for healthcare professionals: KITES randomized study

L. Plachy, V. Neuman, K. Velichova, MG. Slavenko, A. Santova, S. Anne Amaratunga, B. Obermannova, S. Kolouskova, S. Pruhova, Z. Sumnik, L. Petruzelkova

. 2024 ; 209 (-) : 111602. [pub] 20240302

Jazyk angličtina Země Irsko

Typ dokumentu randomizované kontrolované studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24006836

AIMS: To evaluate glucose control non-inferiority and time benefits of telemedicine follow-up in children with type 1 diabetes (CwD). METHODS: In a single-center 9-month-long randomized controlled study (clinicaltrials.gov NCT05484427), 50 children were randomized to either telemedicine group (TG) followed-up distantly by e-mail, or to face-to-face group (FFG) attending standard personal visits. The primary endpoint was non-inferiority of HbA1c at final visit (level of non-inferiority was set at 5 mmol/mol). The secondary endpoints were subcutaneous glucose monitoring parameters and time consumption from both study subjects' and the physicians' point of view. RESULTS: Non-inferiority of HbA1c in the TG was proven (mean HbA1C 45.8 ± 7.3 [TG] vs. 50.0 ± 12.6 [FFG] mmol/mol, 6.3 vs. 6.7 % DCCT, p = 0.17; between groups HbA1C difference 95 % CI -10.2 to 1.9 mmol/mol). Telemedicine saved time for participants (mean visit duration [MVD] 50 [TG] vs. 247 min [FFG], p < 0.001). There were no other differences between groups neither in CGM parameters nor physician's time consumption (MVD 19 [TG] vs. 20 min [FFG], p = 0.58). CONCLUSIONS: Nine-month telemedicine follow-up of the children with well-controlled T1D is not inferior to standard face-to-face visits. Telemedicine visits saved time for the participants but not for their diabetologists.

000      
00000naa a2200000 a 4500
001      
bmc24006836
003      
CZ-PrNML
005      
20240423155527.0
007      
ta
008      
240412e20240302ie f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.diabres.2024.111602 $2 doi
035    __
$a (PubMed)38437986
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ie
100    1_
$a Plachy, Lukas $u Department of Pediatrics of Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, Prague, 15000, Czech Republic. Electronic address: lukas.plachy@fnmotol.cz
245    10
$a Telemedicine maintains good glucose control in children with type 1 diabetes but is not time saving for healthcare professionals: KITES randomized study / $c L. Plachy, V. Neuman, K. Velichova, MG. Slavenko, A. Santova, S. Anne Amaratunga, B. Obermannova, S. Kolouskova, S. Pruhova, Z. Sumnik, L. Petruzelkova
520    9_
$a AIMS: To evaluate glucose control non-inferiority and time benefits of telemedicine follow-up in children with type 1 diabetes (CwD). METHODS: In a single-center 9-month-long randomized controlled study (clinicaltrials.gov NCT05484427), 50 children were randomized to either telemedicine group (TG) followed-up distantly by e-mail, or to face-to-face group (FFG) attending standard personal visits. The primary endpoint was non-inferiority of HbA1c at final visit (level of non-inferiority was set at 5 mmol/mol). The secondary endpoints were subcutaneous glucose monitoring parameters and time consumption from both study subjects' and the physicians' point of view. RESULTS: Non-inferiority of HbA1c in the TG was proven (mean HbA1C 45.8 ± 7.3 [TG] vs. 50.0 ± 12.6 [FFG] mmol/mol, 6.3 vs. 6.7 % DCCT, p = 0.17; between groups HbA1C difference 95 % CI -10.2 to 1.9 mmol/mol). Telemedicine saved time for participants (mean visit duration [MVD] 50 [TG] vs. 247 min [FFG], p < 0.001). There were no other differences between groups neither in CGM parameters nor physician's time consumption (MVD 19 [TG] vs. 20 min [FFG], p = 0.58). CONCLUSIONS: Nine-month telemedicine follow-up of the children with well-controlled T1D is not inferior to standard face-to-face visits. Telemedicine visits saved time for the participants but not for their diabetologists.
650    _2
$a dítě $7 D002648
650    _2
$a lidé $7 D006801
650    12
$a diabetes mellitus 1. typu $7 D003922
650    _2
$a krevní glukóza $7 D001786
650    _2
$a glykovaný hemoglobin $7 D006442
650    _2
$a selfmonitoring glykemie $7 D015190
650    12
$a telemedicína $7 D017216
650    _2
$a hypoglykemika $7 D007004
655    _2
$a randomizované kontrolované studie $7 D016449
655    _2
$a časopisecké články $7 D016428
700    1_
$a Neuman, Vit $u Department of Pediatrics of Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, Prague, 15000, Czech Republic. Electronic address: vit.neuman@fnmotol.cz
700    1_
$a Velichova, Katerina $u Department of Pediatrics of Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, Prague, 15000, Czech Republic. Electronic address: kacka.velichova@seznam.cz
700    1_
$a Slavenko, Matvei G $u Department of Pediatrics of Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, Prague, 15000, Czech Republic. Electronic address: matvei.slavenko@fnmotol.cz
700    1_
$a Santova, Alzbeta $u Department of Pediatrics of Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, Prague, 15000, Czech Republic. Electronic address: alzbeta.santova@fnmotol.cz
700    1_
$a Anne Amaratunga, Shenali $u Department of Pediatrics of Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, Prague, 15000, Czech Republic. Electronic address: shanali.amaratunga@fnmotol.cz
700    1_
$a Obermannova, Barbora $u Department of Pediatrics of Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, Prague, 15000, Czech Republic. Electronic address: barbora.obermannova@fnmotol.cz
700    1_
$a Kolouskova, Stanislava $u Department of Pediatrics of Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, Prague, 15000, Czech Republic. Electronic address: stepanka.pruhova@lfmotol.cuni.cz
700    1_
$a Pruhova, Stepanka $u Department of Pediatrics of Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, Prague, 15000, Czech Republic. Electronic address: stanislava.kolouskova@lfmotol.cuni.cz
700    1_
$a Sumnik, Zdenek $u Department of Pediatrics of Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, Prague, 15000, Czech Republic. Electronic address: zdenek.sumnik@lfmotol.cuni.cz
700    1_
$a Petruzelkova, Lenka $u Department of Pediatrics of Second Faculty of Medicine, Charles University in Prague and Motol University Hospital, V Uvalu 84, Prague, 15000, Czech Republic
773    0_
$w MED00001385 $t Diabetes research and clinical practice $x 1872-8227 $g Roč. 209 (20240302), s. 111602
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38437986 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423155523 $b ABA008
999    __
$a ok $b bmc $g 2081047 $s 1216603
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 209 $c - $d 111602 $e 20240302 $i 1872-8227 $m Diabetes research and clinical practice $n Diabetes Res Clin Pract $x MED00001385
LZP    __
$a Pubmed-20240412

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...